Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy Participants
暂无分享,去创建一个
N. Gallagher | H. Schran | O. Yin | Robert Harrell | W. Zhou | Ai Li
[1] R. Kim,et al. Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice , 2007, Clinical pharmacology and therapeutics.
[2] K. Bhalla,et al. Clinical pharmacokinetics (PK) of AMN107, a novel inhibitor of Bcr-Abl, in healthy subjects and patients with imatinib resistant or intolerant chronic myelogenous leukemia (CML) or relapsed/refractory Ph+ acute lymphocytic leukemia (Ph+ALL). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] K. Bhalla,et al. Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. , 2006, The New England journal of medicine.
[4] J. Mestan,et al. AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL , 2006, British Journal of Cancer.
[5] J. Mestan,et al. In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. , 2005, Cancer research.
[6] Y. Sawada,et al. CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2005, Drug Metabolism and Disposition.
[7] Donna Neuberg,et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. , 2005, Cancer cell.
[8] P. Neuvonen,et al. Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. , 2004, British journal of clinical pharmacology.
[9] P. Meier,et al. The superfamily of organic anion transporting polypeptides. , 2003, Biochimica et biophysica acta.
[10] P. Dawson,et al. Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.
[11] P. Langguth,et al. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] T. Ohta,et al. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[13] A. S. Gross,et al. Influence of grapefruit juice on cisapride pharmacokinetics , 1999, Clinical pharmacology and therapeutics.
[14] P. Neuvonen,et al. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid , 1998, Clinical pharmacology and therapeutics.
[15] P. Watkins,et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[16] Morton B. Brown,et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. , 1997, The Journal of clinical investigation.
[17] M. Ducharme,et al. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice , 1995, Clinical pharmacology and therapeutics.
[18] M. Ducharme,et al. Trough concentrations of cyclosporine in blood following administration with grapefruit juice. , 1993, British journal of clinical pharmacology.
[19] B. Edgar,et al. Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans , 1991, Clinical pharmacology and therapeutics.
[20] D. Bailey,et al. Interaction of citrus juices with felodipine and nifedipine , 1991, The Lancet.
[21] Y. Sawada,et al. Effects of Grapefruit Juice and Orange Juice on the Intestinal Efflux of P-Glycoprotein Substrates , 2004, Pharmaceutical Research.
[22] Y. Sawada,et al. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model. , 2000, British journal of clinical pharmacology.